10 min read
Monthly FDA Guidance and Regulatory News Review - May 2026
This May 2026 regulatory update highlights multiple guidances issued by the FDA across cell and gene therapy, clinical...
May 12-13, 2026 – New Brunswick, NJ
⚛️ Where Clinical Operations Meet Real-World Execution
Veristat is pleased to attend OCT East Coast 2026, a leading event for clinical operations leaders focused on the realities of trial execution. As protocols grow more complex and timelines compress, success depends on more than activity. It depends on alignment, discipline, and decisions that hold up under pressure.
Our team looks forward to connecting with clinical and operational leaders to discuss how Veristat helps sponsors reduce rework, improve decision speed, and make every dollar of development capital count.
👥 Meet with us at OCT East Coast
Connect with us to explore how Veristat’s scientific leadership and focused capabilities support confident decisions and efficient progress across clinical and regulatory milestones.
📅 Schedule a meeting in advance
Complete the form on this page to reserve time with our team. We welcome the opportunity to learn about your upcoming programs and explore how Veristat can support your development strategy.
💡 Our Expertise
Veristat’s work centers on the capabilities sponsors need most as programs move toward key development and regulatory milestones:
-
Phase I-II Clinical Development
-
Biostatistics and Data-Driven Evidence
- Global Regulatory Strategy & Submissions
Together, these capabilities help sponsors move from study design to submission with clarity, reduce rework, and accelerate progress toward patients while preserving development capital.
Schedule A Meeting
Meet with us at OCT East Coast
New Brunswick, NJ | May 12-13
7 min read
Monthly FDA Guidance and Regulatory News Review - April 2026
May 20, 2026 Veristat Blog
This April 2026 regulatory update highlights new policies on biomarker validation, expanded access to investigational...